{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:56:24Z","timestamp":1772484984948,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"DOI":"10.7759\/cureus.104556","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:59:56Z","timestamp":1772481596000},"source":"Crossref","is-referenced-by-count":0,"title":["Upper Limb Paralysis as Presentation of Hepatocellular Carcinoma Bone Metastases"],"prefix":"10.7759","author":[{"given":"Patr\u00edcia","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carm\u00e9lia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101571","article-title":"Hepatocellular carcinoma: epidemiology, diagnosis and treatment","volume":"7","author":"Mauro E","year":"2025","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V, Llovet JM. Hepatocellular carcinoma: epidemiology, diagnosis and treatment. JHEP Rep. 2025, 7:101571. 10.1016\/j.jhepr.2025.101571","journal-title":"JHEP Rep"},{"key":"ref2","unstructured":"NIH. Liver cancer causes, risk factors, and prevention. (2024). Accessed: February 1, 2026: https:\/\/www.cancer.gov\/types\/liver\/what-is-liver-cancer\/causes-risk-factors."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13070207","article-title":"Hepatocellular carcinoma: a comprehensive review","volume":"13","author":"Amin N","year":"2025","unstructured":"Amin N, Anwar J, Sulaiman A, Naumova NN, Anwar N. Hepatocellular carcinoma: a comprehensive review. Diseases. 2025, 13:207. 10.3390\/diseases13070207","journal-title":"Diseases"},{"key":"ref4","article-title":"Clinical features and diagnosis of hepatocellular carcinoma","author":"Schwartz JM","year":"2025","unstructured":"Schwartz JM, Carithers RL, Sirlin CB. Clinical features and diagnosis of hepatocellular carcinoma. UpToDate. Connor RF (ed): Wolters Kluwer, Waltham, MA; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-021-00612-z","article-title":"Hepatocellular carcinoma with uncommon sites of metastasis: a rare case report","volume":"52","author":"Targe M","year":"2021","unstructured":"Targe M, Yasam VR, Nagarkar R. Hepatocellular carcinoma with uncommon sites of metastasis: a rare case report. Egypt J Radiol Nucl Med. 2021, 52:228. 10.1186\/s43055-021-00612-z","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3229-9","article-title":"Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective","volume":"59","author":"Abbas A","year":"2014","unstructured":"Abbas A, Medvedev S, Shores N, Bazzano L, Dehal A, Hutchings J, Balart L. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci. 2014, 59:2813-20. 10.1007\/s10620-014-3229-9","journal-title":"Dig Dis Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-017-9998-6","article-title":"Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management\u2014single-center experience","volume":"48","author":"Bhatia R","year":"2017","unstructured":"Bhatia R, Ravulapati S, Befeler A, Dombrowski J, Gadani S, Poddar N. Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management\u2014single-center experience. J Gastrointest Cancer. 2017, 48:321-5. 10.1007\/s12029-017-9998-6","journal-title":"J Gastrointest Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943866","article-title":"Emerging perspectives of bone metastasis in hepatocellular carcinoma","volume":"12","author":"Yuan X","year":"2022","unstructured":"Yuan X, Zhuang M, Zhu X, et al.. Emerging perspectives of bone metastasis in hepatocellular carcinoma. Front Oncol. 2022, 12:943866. 10.3389\/fonc.2022.943866","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-013-9454-4","article-title":"Bone metastases in hepatocellular carcinoma: an emerging issue","volume":"33","author":"Longo V","year":"2014","unstructured":"Longo V, Brunetti O, D'Oronzo S, Ostuni C, Gatti P, Silvestris F. Bone metastases in hepatocellular carcinoma: an emerging issue. Cancer Metastasis Rev. 2014, 33:333-42. 10.1007\/s10555-013-9454-4","journal-title":"Cancer Metastasis Rev"},{"key":"ref10","article-title":"Bone metastases as the initial presentation of hepatocellular carcinoma. Two case reports and a literature review","volume":"13","author":"Ruiz-Morales JM","year":"2014","unstructured":"Ruiz-Morales JM, Dorantes-Heredia R, Chable-Montero F, Vazquez-Manjarrez S, M\u00e9ndez-S\u00e1nchez N, Motola-Kuba D. Bone metastases as the initial presentation of hepatocellular carcinoma. Two case reports and a literature review. Ann Hepatol. 2014, 13:838-42.","journal-title":"Ann Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(16)60173-X","article-title":"Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors","volume":"16","author":"Lu Y","year":"2017","unstructured":"Lu Y, Hu JG, Lin XJ, et al.. Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors. Hepatobiliary Pancreat Dis Int. 2017, 16:499-505. 10.1016\/S1499-3872(16)60173-X","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S342266","article-title":"Recurrent hepatocellular carcinoma: patterns, detection, staging and treatment","volume":"9","author":"Papaconstantinou D","year":"2022","unstructured":"Papaconstantinou D, Tsilimigras DI, Pawlik TM. Recurrent hepatocellular carcinoma: patterns, detection, staging and treatment. J Hepatocell Carcinoma. 2022, 9:947-57. 10.2147\/JHC.S342266","journal-title":"J Hepatocell Carcinoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S417273","article-title":"Effects of clinical and tumor characteristics on survival in patients with hepatocellular carcinoma with bone metastasis","volume":"10","author":"Ozer M","year":"2023","unstructured":"Ozer M, Goksu SY, Lin RY, et al.. Effects of clinical and tumor characteristics on survival in patients with hepatocellular carcinoma with bone metastasis. J Hepatocell Carcinoma. 2023, 10:1129-41. 10.2147\/JHC.S417273","journal-title":"J Hepatocell Carcinoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02093-6","article-title":"Variability in biopsy quality informs translational research applications in hepatocellular carcinoma","volume":"11","author":"Weinfurtner K","year":"2021","unstructured":"Weinfurtner K, Cho J, Ackerman D, et al.. Variability in biopsy quality informs translational research applications in hepatocellular carcinoma. Sci Rep. 2021, 11:22763. 10.1038\/s41598-021-02093-6","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S147097","article-title":"Extrahepatic metastasis risk of hepatocellular carcinoma based on \u03b1-fetoprotein and tumor staging parameters at cross-sectional imaging","volume":"9","author":"Yokoo T","year":"2017","unstructured":"Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I. Extrahepatic metastasis risk of hepatocellular carcinoma based on \u03b1-fetoprotein and tumor staging parameters at cross-sectional imaging. Cancer Manag Res. 2017, 9:503-11. 10.2147\/CMAR.S147097","journal-title":"Cancer Manag Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal AG","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, et al.. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023, 78:1922-65. 10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9098(199702)64:2<143::aid-jso10>3.0.co;2-7","article-title":"Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection","volume":"64","author":"Shirabe K","year":"1997","unstructured":"Shirabe K, Takenaka K, Gion T, Shimada M, Fujiwara Y, Sugimachi K. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Surg Oncol. 1997, 64:143-6. 10.1002\/(sici)1096-9098(199702)64:2&lt;143::aid-jso10&gt;3.0.co;2-7","journal-title":"J Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14525-w","article-title":"Prognostic value of serum \u03b1-fetoprotein level as an important characteristic of tumor biology for patients undergoing liver resection of early-stage hepatocellular carcinoma (BCLC stage 0\/A): a large multicenter analysis","volume":"31","author":"Yao LQ","year":"2024","unstructured":"Yao LQ, Fan ZQ, Wang MD, et al.. Prognostic value of serum \u03b1-fetoprotein level as an important characteristic of tumor biology for patients undergoing liver resection of early-stage hepatocellular carcinoma (BCLC stage 0\/A): a large multicenter analysis. Ann Surg Oncol. 2024, 31:1219-31. 10.1245\/s10434-023-14525-w","journal-title":"Ann Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2024.06.007","article-title":"Alcohol and hepatocellular carcinoma","volume":"28","author":"Ha NB","year":"2024","unstructured":"Ha NB, Yao F. Alcohol and hepatocellular carcinoma. Clin Liver Dis. 2024, 28:633-46. 10.1016\/j.cld.2024.06.007","journal-title":"Clin Liver Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452890-upper-limb-paralysis-as-presentation-of-hepatocellular-carcinoma-bone-metastases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:59:58Z","timestamp":1772481598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452890-upper-limb-paralysis-as-presentation-of-hepatocellular-carcinoma-bone-metastases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.104556","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}